Skip to main content
An evaluation of a common psoriasis drug's effect on one cardiometabolic risk factor instead showed a favorable impact on a different one.
ICYMI: Your Rheumatoid Questions from RNL 2022

Rheumatologists questions for Dr. Jack Cush QD

Clinic is sponsored by R

Dr. John Cush RheumNow

4 years 5 months ago
ICYMI: Your Rheumatoid Questions from RNL 2022 Rheumatologists questions for Dr. Jack Cush QD Clinic is sponsored by RheumNow's PsA All the Way Campaign in April 2022 https://t.co/gNk77DIEKK https://t.co/kxJVvRnmkH
Study of 221 active RA pts starting a DMARD showed that Sleep disturbance significantly predicted subsequent pain sensit

Dr. John Cush RheumNow

4 years 5 months ago
Study of 221 active RA pts starting a DMARD showed that Sleep disturbance significantly predicted subsequent pain sensitization and conditioned pain modulation. https://t.co/zcUVaMemXN https://t.co/5timIb0aeG
ICYMI: Your Lupus Questions from RNL 2022
Rheumatologists questions for Dr. Jack Cush

QD Clinic is sponsored by RheumNo

Dr. John Cush RheumNow

4 years 5 months ago
ICYMI: Your Lupus Questions from RNL 2022 Rheumatologists questions for Dr. Jack Cush QD Clinic is sponsored by RheumNow's PsA All the Way Campaign in April 2022 https://t.co/5caTUJIYtr https://t.co/wCraFM8SwW
ICYMI: Japanese study using Mendelian randomization (MR) analysis of the association between coffee consumption, gout &a

Dr. John Cush RheumNow

4 years 5 months ago
ICYMI: Japanese study using Mendelian randomization (MR) analysis of the association between coffee consumption, gout & uric acid levels - showing coffee consumption can causally reduce gout risk (OR = 0.50), independent of SUA levels https://t.co/aTGkbKDXMg https://t.co/fJqS4nxvDs
ICYMI: Study of 1899 ankylosing spondylitis pts(10 RCTs) shows TNFi resp can be predicted - 34% had major resp vs 34% w

Dr. John Cush RheumNow

4 years 5 months ago
ICYMI: Study of 1899 ankylosing spondylitis pts(10 RCTs) shows TNFi resp can be predicted - 34% had major resp vs 34% w/ no resp @ wk12. A major resp increased w/ higher CRP, Pt Global & BASDAI-Q2 score & decr w/ higher BMI & BASFI https://t.co/Zo0PFiV3ro https://t.co/FsIiAaykpC
ICYMI: Free Teaching PDF on "What is Rheumatoid Arthritis" from JAMA https://t.co/gf2TBv3AjD

Dr. John Cush RheumNow

4 years 5 months ago
ICYMI: Free Teaching PDF on "What is Rheumatoid Arthritis" from JAMA https://t.co/gf2TBv3AjD
ICYMI: Study of 119 SLE pts (30 w CKD) shows urinary galectin-3 binding protein as a biomarker, increased w/ active LN,

Dr. John Cush RheumNow

4 years 5 months ago
ICYMI: Study of 119 SLE pts (30 w CKD) shows urinary galectin-3 binding protein as a biomarker, increased w/ active LN, significantly (p<0.001)correlating w/ SLEDAI, SLICC RAS, histologic activity; higher in proliferative vs membranous LN (p=0.04) https://t.co/uUfwJm7JbE https://t.co/mh61wlBN87
ICYMI: Infection in lupus is suggested by v. high CRP, PMN-lymph ratio (NLR) Plt-lymph ratio(PLR). Study of 104 hospital

Dr. John Cush RheumNow

4 years 5 months ago
ICYMI: Infection in lupus is suggested by v. high CRP, PMN-lymph ratio (NLR) Plt-lymph ratio(PLR). Study of 104 hospitalized SLE found all v.high w/ infx & Combined cutoffs of CRP >20 mg/L, NLR >3.5, PLR >151 had 87 sensitivity & 81% specificity for infx https://t.co/OOd5Mftnhl https://t.co/GqSI7HLsbY
PsA All the Way – All April Long

Join us all April long for our focus on PsA. Tweets, articles, blogs, therapeutic up

Dr. John Cush RheumNow

4 years 5 months ago
PsA All the Way – All April Long Join us all April long for our focus on PsA. Tweets, articles, blogs, therapeutic updates and more...all this month! https://t.co/KEDx73TYHL https://t.co/GaTZ00dQ4N
Your Hot Topic Questions from RNL 2022

Rheumatologists questions for Dr. Jack Cush

QD Clinic is sponsored by RheumNow'

Dr. John Cush RheumNow

4 years 5 months ago
Your Hot Topic Questions from RNL 2022 Rheumatologists questions for Dr. Jack Cush QD Clinic is sponsored by RheumNow's PsA All the Way Campaign in April 2022 https://t.co/wpPeIwiCxe https://t.co/UY3gDaVeTv
Increased Cancer Risk with Autoimmune Disorders (AID)

The incidence and mortality of cancer among AID was studied in a

Dr. John Cush RheumNow

4 years 5 months ago
Increased Cancer Risk with Autoimmune Disorders (AID) The incidence and mortality of cancer among AID was studied in a large Chinese cohort, demonstrating that while onset time and risks vary, there is an increased risk of malignancy in AID. https://t.co/T2WkOWp0cA https://t.co/iNJioAvrIe
×